skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I need some fixed income suggestions for my RRSP. Anything you particularly like at this time? I know its fixed income but I do have some risk tolerance and a 17 year investment horizon so open to something that pays more than .0000012% interest. Appreciate your thoughts :)

As always.. amazing job team!
Read Answer Asked by Don on February 10, 2021
Q: Seems bewildering to choose among so many types of Tech stocks. Looking for 3 names...would CRM, ADBE or any others you would suggest be worthy at today’s values or should I just run to the SMH ETF? Help and thanks!
Read Answer Asked by Michael on February 10, 2021
Q: Can you enlighten me on Bitcoin.
I was under the impression that it was illegal in the United States to use any form of Money for the purchase of goods, other than dollars issued by the Federal Reserve.
Thanks Gord


Read Answer Asked by Gordon on February 10, 2021
Q: Please provide a total of 12 stocks(Can.& US) that will do well in inflation. By the way,what are the chances of inflation even though the Fed is keeping rate low as long as possible.Thanks for u usual great services & views.
Read Answer Asked by Peter on February 10, 2021
Q: Hi. Can I have your views on the following scenario: Currently Canopy Growth is sitting at a market cap of 21B. Aphria + Tilray at about 13B. If I am not mistaken, Aphria + Tilray beats Canopy in all the important financial metrics. Does Canopy have a better future growth profile then Aphria + Tilray, or is there a market mismatch here? (APHA up 13.5% today...)
Read Answer Asked by John on February 09, 2021
Q: For a conservative investor, how much overlap is there in a portfolio comprised of xtr, zmi, pinc, and vrif? Thanks.
Read Answer Asked by Paul W on February 09, 2021
Q: Would you please recommend a couple of inverse etf's or bear funds to hedge the current market enthusiasm. Both Cdn and US pls. Thanks.
Read Answer Asked by John on February 09, 2021
Q: Sold a put for OSB expires April 16, 2021 $44.00 strike. As things are now, my investing account showes a $492.00 loss. I find difficult how it shows a loss when OSB was taken out at $56.00 (give or take). I'm guessing that $12.00 is being discounted for difference in strike and take out price while approximately $30.00 extra for the WFT is being baked in. When the option expires will I potentially be holding 100 shares of WFG?
Read Answer Asked by Anthony on February 09, 2021
Q: Responding to Wilson on Dec 21 you stated that Acuity Ads was moving up based on a "comparable valuation move" relative to TTD based on "price to sales" and that "momentum in the stock is about the best we have seen".  Valuation relative to competitor MGNI was also mentioned in your response.  Since then AT is up approx 40% while TTD is flat, and MGNI has more than doubled.  Please provide an update on the current relative valuation of AT, TTD and MGNI using the price to sales metric (and any additional metric that you feel may be relevant).  Do you consider AT to still be significantly undervalued relative to TTD and MGNI?  Looking ahead, is it a takeover target?  Do you think that the current momentum on AT will push it higher?  Are there any catalysts on the horizon that may push it higher?  Thanks to 5i I have a substantial position in AT with a cost base of $1.46.  I really like to let my winners run but sitting on a holding with a 19x gain, I need to decide if/when to liquidate some of the position.....thank you.
Read Answer Asked by Glenn on February 09, 2021
Q: What is your opinion of Invesco International Fund Series F or other Invesco International Fund Series?
Read Answer Asked by Donald on February 09, 2021
Q: Hello Peter,
With the US elections and the senate win by the democrats, I was expecting that the US cannabis stocks would surge alot more than the Canadian ones. However, this is not the case and am wondering what that is.. For example. if you look at Aphria and Tilray, and Organirams, they have surged alot more than companies that are actually making money like Curaleaf in the USA .. Do you think this is because US companies are not surging as much due to them being on CDNX (not on TSX or NYSE) and may not be readily available for US investors..Also, can you comment on why Medmen is going through the roof in the last 5 days..? thanks very much
Read Answer Asked by umedali on February 09, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!